Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole

International Journal of Clinical Pharmacology and Therapeutics

Volumn 49, Issue 4, 2011, Pages 291-292

  Inoue, Y ^a   Saito, T ^b   Takimoto, M ^b   Ogawa, K ^b   Shibuya, Y ^b   Suzuki, Y ^b   Kato, M ^b   Takahashi, M ^b   Miura, I ^b   Hatta, Y ^a   Takeuchi, J ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TACROLIMUS; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG METABOLISM; ENGRAFTMENT; FEMALE; FUNGAL PLEURITIS; HUMAN; LETTER; PLEURISY; STEADY STATE;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PYRIMIDINES; TACROLIMUS; TRIAZOLES;

EID: 79955978489     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP49291     Document Type: Letter

References (6)

1. Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S,Warty V, McMichael J, Lever J, Burckart G, Starzl T. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995; 29: 404-430. (Pubitemid 26004179)
2. Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, Roberts JP, HebertMF. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther. 1997; 62: 41-49.
3. Mihara A, Mori T, Aisa Y, Yamazaki R, Iketani O, Tanigawa Y, Ikeda Y, Okamoto S. Greater impact of fluconazole on drug interaction with intravenous tacrolimus as compared with intravenous fluconazole. Eur J Clin Phamacol. 2008; 64: 89-91.
4. Boyd AE, Modi S, Howard SJ, Moore CB, Keevil BG, Denning DW. Adverse reaction to voriconazole. Clin Infect Dis. 2004; 39: 1241-1244.
5. Saad AH, DePestel DD, Carver PL. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy. 2006; 26: 1730-1744. (Pubitemid 44885328)
6. Schultz KR, Nevill TJ, Balshaw RF, Toze CL, Corr T, Currie CJ, Strong DK, Keown PA. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporine Ain the first month after bone marrow transplantation. Bone MarrowTransplant. 2000; 26: 545-551.